A Director at Cardiovascular Systems (NASDAQ: CSII) is Selling SharesBy Carrie Williams
In addition to Leslie Trigg, 6 other CSII executives reported Sell trades in the last month. Following Leslie Trigg’s last CSII Sell transaction on August 23, 2016, the stock climbed by 2.6%.
Based on Cardiovascular Systems’ latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $49.8 million and GAAP net loss of $1.86 million. In comparison, last year the company earned revenue of $43.87 million and had a GAAP net loss of $13.26 million. The company has a one year high of $27.38 and a one year low of $7.50. Currently, Cardiovascular Systems has an average volume of 250K.
Based on 3 analyst ratings, the analyst consensus is Strong Buy with an average price target of $29.00, reflecting a -9.0% downside.
The insider sentiment on Cardiovascular Systems has been negative according to 38 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Cardiovascular Systems, Inc. is a medical device company, which develops and sells devices for treating cardiovascular diseases. It focuses on developing and commercializing minimally invasive treatment solutions for vascular diseases. The company’s products such as diamondback 360° PAD system and the stealth 360° PAD system are catheter based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee. The company was founded in 2000 and is headquartered in St. Paul, MN.